Study Stopped
due to lack of interest
China Post-market Study of the INCRAFT® AAA Stent Graft System in Subjects With Abdominal Aortic Aneurysms (INITIATION)
A Multicenter, Open Label, Prospective, Post-Market Study of the INCRAFT AAA Stent Graft in Subjects With Abdominal Aortic Aneurysms
1 other identifier
observational
N/A
1 country
1
Brief Summary
INITIATION is a postmarket clinical follow-up study in China. The purpose of the study is to continue to evaluate the safety and effectiveness/performance of Incraft in subjects with abdominal aortic aneurysms requiring endovascular repair in routine clinical practice. Approximately 120 subjects will be enrolled and followed through 1-years postprocedure. Up to 20 sites in China may participate.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Aug 2019
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 15, 2019
CompletedFirst Posted
Study publicly available on registry
May 29, 2019
CompletedStudy Start
First participant enrolled
August 31, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2021
CompletedFebruary 26, 2021
February 1, 2021
1 year
May 15, 2019
February 24, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Absence of major adverse events
MAE is defined as the combination of death, myocardial infarction, stroke/cerebrovascular accident, and renal failure.
Within 30-days post-procedure
Secondary Outcomes (7)
Occurence of major adverse events
Through 1 year post-procedure
Technical success
At the conclusion of the index procedure
Absence of stent graft migration(>10mm)
Assessed at 1 year
Absence of Type I or Type III endoleak and no aneurysm enlargement (growth >5mm)
Assessed at 1 year compared to size measurement at 1 month
Absence of stent graft fracture
Assessed within 30-days and 1-year post-procedure
- +2 more secondary outcomes
Study Arms (1)
INCRAFT
Endovascular abdominal aortic aneurysm repair
Interventions
Device: Endovascular abdominal aortic aneurysm repair Subjects with infrarenal abdominal aortic aneurysms who meet all inclusion criteria and none of the exclusion criteria will be treated with the INCRAFT Stent Graft System.
Eligibility Criteria
Patients who are eligible for endovascular repair of an abdominal aortic aneurysm
You may qualify if:
- Male or female aged 18 and over
- The femoral access vessel is adequate for the selected delivery system;
- Length of proximal aneurysmal neck ≥ 10mm;
- Aortic neck diameter ≥ 17mm and ≤ 31mm;
- The aortic neck is suitable for suprarenal fixation;
- The angle of the infrarenal and suprarenal neck is ≤60 degrees;
- Iliac fixation length ≥ 15mm;
- Iliac diameter ≥ 7mm and ≤ 22mm;
- Minimum total AAA treatment length (proximal landing point to distal landing point) ≥ 128mm;
- Morphology is suitable for aneurysm repair;
- Written informed consent form shall be provided prior to initiating any study protocol;
- The subject is willing to follow the prescribed follow-up schedule.
You may not qualify if:
- The subject has one of the following conditions:
- Aneurysm sac rupture or leaking abdominal aortic aneurysm
- Mycotic, dissecting, or inflammatory abdominal aortic aneurysm;
- Known to be allergic or intolerant to nickel titanium (Nitinol), polyethylene terephthalate (PET) or polytetrafluoroethylene (PTFE);
- Known contraindication to undergoing angiography or anticoagulation
- Existing AAA surgical graft and/or a AAA stent-graft system;
- Women of child bearing potential whom are pregnant, lactating, or planning to become pregnant during the course of the trial;
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cordis US Corp.lead
Study Sites (1)
Beijing Anzhen Hospital
Beijing, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Zhong Chen, Doctor
Beijing Anzhen Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Year
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 15, 2019
First Posted
May 29, 2019
Study Start
August 31, 2019
Primary Completion
August 31, 2020
Study Completion
December 31, 2021
Last Updated
February 26, 2021
Record last verified: 2021-02